Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.56 |
| ▸ | CA2 | P00918 | 2/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | ACACB | O00763 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | KDM1A | O60341 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ACP3 | P15309 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13462356 | 1.00 | CA1 (0.56) | CA1CA2ACHEALDH1A1CYP2D6 | |
| SCHEMBL8239398 | 1.00 | CA1 (0.56) | CA1CA2ACHEALDH1A1CYP2D6 | |
| Hydrochloric Acid SCHEMBL3654829 | 0.98 | CA1 (0.55) | CA1CA2ACHEALDH1A1CYP2D6 | |
| SCHEMBL28660520 | 0.84 | CA1 (0.58) | CA1CA2ACHEALDH1A1CA12 | |
| SCHEMBL24258312 | 0.82 | ALOX5 (0.60) | CYP2D6TDP1L3MBTL1TSHRMAPT | |
| SCHEMBL28277742 | 0.82 | CA1 (0.56) | CA1CA2ACHEALDH1A1CA12 | |
| SCHEMBL24105692 | 0.82 | CA1 (0.56) | CA1CA2ACHEALDH1A1CYP2D6 | |
| SCHEMBL19286211 | 0.82 | CA1 (0.56) | CA1CA2ACHEALDH1A1CA12 | |
| SCHEMBL8284262 | 0.80 | ACACB (0.50) | ALDH1A1CYP2D6ACACBMAPK1MEN1 | |
| SCHEMBL24105676 | 0.80 | CA1 (0.55) | CA1CA2ACHEALDH1A1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1656349-B1 | CYCLOPROPYL DERIVATIVES AS NK3 RECEPTOR ANTAGONISTS | LUNDBECK & CO AS H (DK) | 2011-10-12 | — | — | EP | claimed |
| CN-119040223-B | Lactobacillus rhamnosus RH22 with anti-inflammatory and antiallergic effects and application thereof | 微康益生菌(苏州)股份有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119040223-A | Lactobacillus rhamnosus RH22 with anti-inflammatory and antiallergic effects and application thereof | 微康益生菌(苏州)股份有限公司 | 2024-11-29 | — | — | CN | disclosed |
| CN-114632136-B | Skin external composition with enhanced anti-rash effect | 浙江养生堂天然药物研究所有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-118453459-A | Fermentation product extract and preparation method and application thereof | 浙江立恩生物科技有限公司 | 2024-08-09 | — | — | CN | disclosed |
| CN-114948801-B | Protective composition with relieving effect and preparation method thereof | 深圳减字科技有限公司 | 2024-04-30 | — | — | CN | disclosed |
| CN-117357418-A | Use of natural products in soothing anti-sensitization cosmetics and anti-sensitization drugs | 上海致臻志臣科技有限公司 | 2024-01-09 | — | — | CN | disclosed |
| CN-116891515-A | Antiallergic peptide and application thereof in immune regulation and antiallergic | 绿茵生技股份有限公司 | 2023-10-17 | — | — | CN | disclosed |
| CN-116785296-A | PLK1 inhibitor and application thereof | 河北渤腾医药技术有限公司 | 2023-09-22 | — | — | CN | disclosed |
| CN-113662869-B | Compound for promoting extracellular matrix gene expression and preparation method thereof | 南京斯拜科生物科技股份有限公司 | 2023-09-15 | — | — | CN | disclosed |
| WO-2008099994-A1 | BIPHENYL DIOL DERIVATIVES AND COMPOSITIONS COMPRISING THE SAME AS AN ACTIVE INGREDIENT | BIOSPECTRUM INC. (KR) | 2008-08-21 | — | — | WO | disclosed |
| EP-1909581-A2 | ADIPOSE TISSUE STEM CELLS, PERIVASCULAR CELLS AND PERICYTES | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2008-04-16 | — | — | EP | disclosed |
| US-20070197522-A1 | Dpp-iv inhibitors | SANTHERA PHARMACEUTICALS (SCHWEIZ) GMBH (CH) | 2007-08-23 | — | — | US | disclosed |
| US-7247648-B2 | N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones | THE PROCTER & GAMBLE COMPANY (US) | 2007-07-24 | — | — | US | disclosed |
| WO-2007019107-A2 | ADIPOSE TISSUE STEM CELLS, PERIVASCULAR CELLS AND PERICYTES | UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) | 2007-02-15 | — | — | WO | disclosed |
| US-20040097560-A1 | N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones | THE PROCTER & GAMBLE COMPANY | 2004-05-20 | — | — | US | disclosed |
| EP-0034415-B1 | 1-(CYCLOHEXYL OR CYCLOHEXENYL)-4-ARYL-4-PIPERIDINECARBOXYLIC ACID DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1984-05-30 | — | — | EP | disclosed |
| US-4369184-A | ANTIHISTAMINES; HETEROCYCLIC NITRILES | JANSSEN PHARMACEUTICA N.V. (BE) | 1983-01-18 | — | — | US | disclosed |
| EP-0034415-A1 | 1-(Cyclohexyl or cyclohexenyl)-4-aryl-4-piperidinecarboxylic acid derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1981-08-26 | — | — | EP | disclosed |
| US-4134980-A | Phenylalkylamino-alkyl derivatives of quinazolinone and phthalazinone | BOEHRINGER INGELHEIM GMBH (DE) | 1979-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097560-A1 | N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones | IL17A, CYP51A1, CD4 | CA1 4833/4885CA2 4713/4885ACHE 2865/4885 |
| US-20070197522-A1 | Dpp-iv inhibitors | DPP7, DPP4, DPP3 | CA1 2245/4885CA2 410/4885ACHE 180/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.